Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
batificaban
- Development stage
- Unknown
- Lead developer
- Bio-Thera Solutions
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Batificaban (BAT-2094) is a small molecule glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonist developed by Bio-Thera Solutions. It is primarily indicated for antithrombotic therapy in patients with acute coronary syndrome (ACS), including unstable angina and non-ST-elevation myocardial infarction (NSTEMI), who are undergoing percutaneous coronary intervention (PCI). Batificaban works by reversibly binding to the integrin alpha-IIb/beta-3 receptor on the surface of platelets, which prevents the binding of fibrinogen and other adhesive ligands. This action inhibits the final common pathway of platelet aggregation, thereby reducing the risk of thrombotic events such as stent thrombosis and periprocedural myocardial infarction. The drug is typically administered as an intravenous injection followed by an infusion during and after the cardiac procedure.
- Other names
- batificaban
02
Targets
GPIIb/IIIa (Integrin alpha-IIb/beta-3)
Beyond the preview
Go deeper on batificaban.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on batificaban.